Oncosec Medical Inc
ONCSDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444307
Oncosec Medical Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Feb 9, 2023; 23 institutions reported holding it in 13F filings for Q3 2022, worth $2.51M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Oncosec Medical Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ONCS is no longer listed, and 13F filings after Q3 2022 list far fewer holders. See Q3 2022
- Institutional holders
- 0
- −22 vs. Q3 2022
- Shares held
- 0
- −5.12M (−100.0%) vs. Q3 2022
- Total value
- $0
- −$2.50M (−100.0%) vs. Q3 2022
- New holders
- 0
- 0 more added
- Sold out
- 22
- 0 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 23 | $2.51M |
| Q2 2022 | 26 | $3.86M |
| Q1 2022 | 31 | $6.09M |
| Q4 2021 | 35 | $5.31M |
| Q3 2021 | 33 | $13.8M |
| Q2 2021 | 36 | $19.2M |
| Q1 2021 | 35 | $36.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Oncosec Medical Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 0 | $0 | 0.00% | −2,945,000−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −717,486−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −383,491−100.0% | Sold out |
| Salzhauer Michael | 0 | $0 | 0.00% | −296,282−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −274,196−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −75,500−100.0% | Sold out |
| Long Focus Capital Management, LLC | 0 | $0 | 0.00% | −69,226−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −67,398−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −62,229−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −43,729−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −39,996−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −30,980−100.0% | Sold out |
| Sandbox Financial Partners, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,640−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,954−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,935−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −11,850−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −6,529−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,567−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Regentatlantic Capital LLC | – | – | – | – | Not filed |